Morgan Stanley’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.5K | Sell |
|
|||||
|
2025
Q1 | $84.1K | Buy |
|
|||||
|
2024
Q4 | $101K | Sell |
|
|||||
|
2024
Q3 | $128K | Sell |
|
|||||
|
2024
Q2 | $138K | Sell |
|
|||||
|
2024
Q1 | $154K | Sell |
|
|||||
|
2023
Q4 | $290K | Buy |
|
|||||
|
2023
Q3 | $128K | Sell |
|
|||||
|
2023
Q2 | $156K | Sell |
|
|||||
|
2023
Q1 | $170K | Buy |
|
|||||
|
2022
Q4 | $48.6K | Sell |
|
|||||
|
2022
Q3 | $146K | Buy |
|
|||||
|
2022
Q2 | $140K | Hold |
|
|||||
|
2022
Q1 | $172K | Sell |
|
|||||
|
2021
Q4 | $234K | Sell |
|
|||||
|
2021
Q3 | $271K | Buy |
|
|||||
|
2021
Q2 | $296K | Sell |
|
|||||
|
2021
Q1 | $284K | Buy |
|
|||||
|
2020
Q4 | $95K | Buy |
|
|||||
|
2020
Q3 | $6K | Buy |
|